Approved For Marketing EXPANDED_ACCESS NCT00528320

Clinical Evaluation of Cardiac Resynchronization Therapy (CRT) Using the Ovatio CRT Implantable Cardioverter-defibrillator (ICD) System

Clinical Evaluation of Cardiac Resynchronization Therapy With Implantable Cardioverter-defibrillator Therapy

Sponsor: ELA Medical, Inc.

Conditions Congestive Heart Failure (CHF)

Interventions Ovatio CRT

Updated 7 times since 2017 Last updated: Nov 26, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00528320, this observational or N/A phase trial focuses on Congestive Heart Failure (CHF) and remains ongoing. Sponsored by ELA Medical, Inc., it has been updated 7 times since 2026, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Approved For Marketing
Jul 2024 — Sep 2024 [monthly]

Approved For Marketing
Jan 2021 — Jul 2024 [monthly]

Approved For Marketing
Jun 2018 — Jan 2021 [monthly]

Approved For Marketing
Apr 2018 — Jun 2018 [monthly]

Approved For Marketing

Phase: NA → None

▶ Show 2 earlier versions

Feb 2017 — Apr 2018 [monthly]

Approved For Marketing NA
Jan 2017 — Feb 2017 [monthly]

Approved For Marketing NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

ELA Medical, Inc.

Data source: ELA Medical, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.